Posted by Michael Wonder on 24 May 2023
Revolutionising MS treatment: new form of Tysabri recommended for PBS listing
24 May 2023 - The PBAC has recommended the listing of natalizumab (Tysabri) pre-filled syringe for subcutaneous injection on the PBS.
This recommendation is for people with relapsing remitting multiple sclerosis, the most common type of MS.
